市场调查报告书
商品编码
1541656
2024-2032 年按产品类型(医用树脂和纤维、医用弹性体、可生物降解塑胶)、应用(医疗设备和装置、医用包装等)和地区分類的医用聚合物市场报告Medical Polymers Market Report by Product Type (Medical Resins and Fibers, Medical Elastomers, Biodegradable Plastics), Application (Medical Equipment and Devices, Medical Packaging, and Others), and Region 2024-2032 |
IMARC Group年全球医用聚合物市场规模达219亿美元。
医用聚合物包括用于製造再生医学和组织工程药物的散装材料、涂层和药物奈米载体。它们具有多功能性、强度、灵活性、生物降解性、生物相容性、灭菌稳定性以及疲劳、耐热和电阻。一些製造商目前正在证明不同类型的医用聚合物,具有调整的分子量、交联和结晶度、共聚物和共混物,以及额外的生物活性表面功能化。此外,对新型和创新医疗设备的需求不断增长,全球对医用聚合物的需求也不断增加,以支持设备的开发和永续性。
诊断和治疗冠状病毒病 (COVID-19) 患者对拭子、医疗设备、一次性口罩和个人防护装备 (PPE) 的需求不断增长,这是推动医用聚合物需求的关键因素之一。除此之外,传染病、慢性病、心血管病和其他慢性病的日益普及正在推动先进医疗设备的采用,这反过来又促进了市场的成长。此外,许多国家的政府正在资助医疗研究与发展 (R&D) 项目,以改善医疗保健基础设施。除此之外,由于老年人口不断增加和事故数量不断增加,对器官移植的需求也不断增加,也推动了市场的发展。此外,医疗旅游的兴起和家庭医疗保健服务的日益普及正在推动市场成长。领先的市场参与者也专注于引入新型复杂的生物聚合物,预计这将增强医用聚合物在骨科稳定材料和血管支架中的应用。
The global medical polymers market size reached US$ 21.9 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 39.1 Billion by 2032, exhibiting a growth rate (CAGR) of 6.5% during 2024-2032.
Medical polymers comprise bulk materials, coatings, and pharmaceutical nano-carriers used for making drugs in regenerative medicine and tissue engineering. They offer versatility, strength, flexibility, biodegradability, biocompatibility, sterilization stability, and fatigue, heat, and electrical resistance. Several manufacturers are currently proving different types of medical polymers with adjusted molecular weight, crosslinking and crystallization degrees, copolymers and blends, and additional bioactive surface functionalization. Moreover, the growing demand for new and innovative medical devices is escalating the need for medical polymers worldwide to support device development and sustainability.
The rising need for swabs, medical devices, disposable masks, and personal protective equipment (PPE) to diagnose and treat individuals with coronavirus disease (COVID-19) represents one of the key factors impelling the demand for medical polymers. Apart from this, the increasing prevalence of infectious, chronic, cardiovascular, and other chronic diseases is propelling the adoption of advanced medical devices, which, in turn, is contributing to the market growth. Additionally, governments of numerous countries are financing medical research and development (R&D) projects to improve healthcare infrastructure. Besides this, the increasing need for organ transplantation due to the growing geriatric population and escalating number of accidents is driving the market. Furthermore, the emerging trend of medical tourism and the increasing popularity of home healthcare services are promoting the market growth. The leading market players are also focusing on introducing new and sophisticated biopolymers, which is projected to enhance the application of medical polymers in orthopedic stabilizing materials and vascular stents.
IMARC Group provides an analysis of the key trends in each sub-segment of the global medical polymers market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on product type and application.
Medical Resins and Fibers
Polyvinyl Chloride
Polypropylene
Polyethylene
Polystyrene
Others
Medical Elastomers
Styrene Block Copolymer
Rubber Latex
Others
Biodegradable Plastics
Medical Equipment and Devices
Medical Packaging
Others
North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
The competitive landscape of the industry has also been examined along with the profiles of the key players being BASF SE, Celanese Corporation, Covestro AG, DuPont, Eastman Chemical Company, Evonik Industries AG, Exxon Mobil Corporation, Huizhou Foryou Medical Device Co. Ltd., Kraton Corporation and Solvay S.A.